Denosumab stalls skeletal-related events in breast ca: Time to a first event was 5 months longer than with zoledronic acid and to hypercalcemia, 7 months - Commentary

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalOncology Report
Issue numberJANUARY
StatePublished - Jan 1 2011

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this